A carregar...

RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine

Cetuximab and panitumumab monoclonal antibodies are a milestone in the history of treatment of metastatic colorectal cancer (mCRC) and point toward future directions for personalized treatment. Recent studies have shown that broader RAS testing is needed to select patients for targeted therapy. The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Appl Immunohistochem Mol Morphol
Main Authors: Valentini, Anna M., Cavalcanti, Elisabetta, Di Maggio, Marianna, Caruso, Maria L.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135466/
https://ncbi.nlm.nih.gov/pubmed/30199395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAI.0000000000000475
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!